EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Imaging and Clinicopathological Features of Squamous Cell Metaplastic Breast Carcinoma: A 22-Case Retrospective Study

Feng Pan, Lei Liu, Dingbao Chen, Yuan Peng

Journal of Clinical Medicine · 21.04.2026 · 15 (8) · 3157

DOI: 10.3390/jcm15083157 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 21.04.2026. Verfasst von Feng Pan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Peking University People's Hospital, Beijing 100044, China. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Squamous cell metaplastic breast carcinoma (SCMBC) is a rare and aggressive breast cancer subtype with limited imaging and prognostic data. This study aimed to characterize the multimodal imaging features, clinicopathological profiles, and prognostic outcomes of SCMBC in a single-center cohort.

Methods

We retrospectively analyzed 22 patients with histopathologically confirmed SCMBC treated between January 2012 and May 2025. Clinicopathological profiles, multimodal imaging features, and prognostic outcomes were collected and evaluated.

Results

All patients were female (median age 64.5 years; range, 34–82). The majority (59.1%) presented with clinical stage II disease. Axillary lymph node metastasis was present in eight (36.4%) patients at diagnosis, with one case of distant lung metastasis. The mean tumor diameter was 4.24 cm (range, 2.1–11.8). MRI findings (n = 13) included heterogeneous internal structure, a low mean apparent diffusion coefficient (ADC) value of 0.98 × 10−3 mm2/s, and frequent necrosis (92.3%). Pathologically, 54.5% of tumors were high-grade, and 81.8% exhibited a triple-negative phenotype. After a median follow-up of 34 months, the 5-year overall survival (OS) rate was 64.3%, while the 3-year disease-free survival (DFS) rate was 42.1%. The recurrence/metastasis rate was 22.7% (5/22), and all five deaths occurred in this subgroup.

Conclusions

SCMBC is characterized by suggestive multimodal imaging features, a predominant triple-negative phenotype, and a high risk of early recurrence. Given the exploratory nature of this single-center study with a limited sample size, these findings require validation in larger, prospective cohorts. Early radiological identification and aggressive personalized treatment strategies may improve outcomes for patients with this aggressive disease.

Schlagwörter

Stichwörter der Autor:innen

magnetic resonance imagingprognosisrecurrencesquamous cell metaplastic breast carcinomatriple-negative breast cancer

Autor:innen und Institutionen

  • Department of Radiology, Peking University People's Hospital, Beijing 100044, China.
  • Department of Pathology, Peking University People's Hospital, Beijing 100044, China.
  • Breast Center, Peking University People's Hospital, Beijing 100044, China.

Zitieren

APA

Pan, F., Liu, L., Chen, D., & Peng, Y. (2026). Imaging and Clinicopathological Features of Squamous Cell Metaplastic Breast Carcinoma: A 22-Case Retrospective Study. Journal of Clinical Medicine, 15(8), 3157. https://doi.org/10.3390/jcm15083157

Vancouver

Pan F, Liu L, Chen D, Peng Y. Imaging and Clinicopathological Features of Squamous Cell Metaplastic Breast Carcinoma: A 22-Case Retrospective Study. Journal of Clinical Medicine. 2026;15(8):3157. doi:10.3390/jcm15083157

BibTeX
@article{Pan2026,
  author = {Pan, Feng and Liu, Lei and Chen, Dingbao and Peng, Yuan},
  title = {Imaging and Clinicopathological Features of Squamous Cell Metaplastic Breast Carcinoma: A 22-Case Retrospective Study},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {8},
  pages = {3157},
  doi = {10.3390/jcm15083157}
}
Kostenlos starten →